Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Janssen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Gastroenterology|February 4, 2009
Hepatologists have addressed these severe complications of liver diseases in many ways, but unfortunately the impact of old and modern therapies on survival once complications of liver disease are manifest, is only minor. PrefaceHarry Janssen, Solko Schalm
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
Preface. Hepatitis C infectionHarry Janssen, Antonio Craxi
European Radiology|March 5, 2020
Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastographyMonica Tafur, Angela Cheung, Ravi J Menezes, et al.
European Radiology|July 28, 2018
The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitisKartik S Jhaveri, Hooman Hosseini-Nik, Nima Sadoughi, et al.
Viruses|July 31, 2019
Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg SeroconversionStijn Van Hees, Heng Chi, Bettina Hansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
Hepatology Communications|November 4, 2022
Leveraging COVID-19 vaccination to promote hepatitis C screeningAaron Vanderhoff, David Smookler, Mia J Biondi, et al.
European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary CholangitisAlessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Gastroenterology|February 4, 2009
Hepatologists have addressed these severe complications of liver diseases in many ways, but unfortunately the impact of old and modern therapies on survival once complications of liver disease are manifest, is only minor. PrefaceHarry Janssen, Solko Schalm
Best Practice & Research. Clinical Gastroenterology|December 4, 2012
Preface. Hepatitis C infectionHarry Janssen, Antonio Craxi
European Radiology|March 5, 2020
Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastographyMonica Tafur, Angela Cheung, Ravi J Menezes, et al.
European Radiology|July 28, 2018
The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitisKartik S Jhaveri, Hooman Hosseini-Nik, Nima Sadoughi, et al.
Viruses|July 31, 2019
Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg SeroconversionStijn Van Hees, Heng Chi, Bettina Hansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis BDarren Wong, Margaret Littlejohn, Rosalind Edwards, et al.
Hepatology Communications|November 4, 2022
Leveraging COVID-19 vaccination to promote hepatitis C screeningAaron Vanderhoff, David Smookler, Mia J Biondi, et al.
European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary CholangitisAlessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, et al.
Pageof 1